- Home
- GLPG vs TUYA Comparison
GLPG vs TUYA Comparison
Compare GLPG & TUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- TUYA
- Stock Information
- Founded
- GLPG 1999
- TUYA 2014
- Country
- GLPG Belgium
- TUYA China
- Employees
- GLPG N/A
- TUYA N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- TUYA Computer Software: Prepackaged Software
- Sector
- GLPG Health Care
- TUYA Technology
- Exchange
- GLPG Nasdaq
- TUYA Nasdaq
- Market Cap
- GLPG 1.8B
- TUYA 1.5B
- IPO Year
- GLPG 2005
- TUYA 2021
- Fundamental
- Price
- GLPG $26.49
- TUYA $2.26
- Analyst Decision
- GLPG Sell
- TUYA
- Analyst Count
- GLPG 4
- TUYA 0
- Target Price
- GLPG $25.33
- TUYA N/A
- AVG Volume (30 Days)
- GLPG 389.2K
- TUYA 2.5M
- Earning Date
- GLPG 04-23-2025
- TUYA 05-19-2025
- Dividend Yield
- GLPG N/A
- TUYA 4.82%
- EPS Growth
- GLPG N/A
- TUYA N/A
- EPS
- GLPG N/A
- TUYA 0.01
- Revenue
- GLPG $311,493,731.00
- TUYA $298,617,000.00
- Revenue This Year
- GLPG $0.08
- TUYA $22.34
- Revenue Next Year
- GLPG $0.23
- TUYA $18.11
- P/E Ratio
- GLPG N/A
- TUYA $250.34
- Revenue Growth
- GLPG 18.32
- TUYA 29.84
- 52 Week Low
- GLPG $22.36
- TUYA $1.28
- 52 Week High
- GLPG $31.23
- TUYA $4.63
- Technical
- Relative Strength Index (RSI)
- GLPG 65.43
- TUYA 40.63
- Support Level
- GLPG $24.31
- TUYA $1.87
- Resistance Level
- GLPG $24.91
- TUYA $2.34
- Average True Range (ATR)
- GLPG 0.83
- TUYA 0.19
- MACD
- GLPG 0.27
- TUYA 0.02
- Stochastic Oscillator
- GLPG 95.59
- TUYA 54.01
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About TUYA Tuya Inc. each representing one
Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, It has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.